MIRA INFORM REPORT

 

 

Report No. :

348596

Report Date :

16.11.2015

 

IDENTIFICATION DETAILS

 

Name :

CARL ZEISS MEDITEC AG

 

 

Registered Office :

Göschwitzer Str. 51-52,  D 07745 Jena

 

 

Country :

Germany

 

 

Financials (as on) :

30.09.2014

 

 

Date of Incorporation :

04.10.1995

 

 

Legal Form :

Public limited company

 

 

Line of Business :

  • Manufacutre of technical instruments and supplies for   medical purposesn.e.c.
  • Wholesale of medical and orthopedic goods, dental and laboratory supplies
  • Other service activities n. e. c.

 

 

No. of Employee :

1,176

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Good

 

 

Payment Behaviour :

No complaints

 

 

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

Germany

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

GERMANY - ECONOMIC OVERVIEW

 

The German economy - the fifth largest economy in the world in PPP terms and Europe's largest - is a leading exporter of machinery, vehicles, chemicals, and household equipment and benefits from a highly skilled labor force. Like its Western European neighbors, Germany faces significant demographic challenges to sustained long-term growth. Low fertility rates and declining net immigration are increasing pressure on the country's social welfare system and necessitate structural reforms. Reforms launched by the government of Chancellor Gerhard SCHROEDER (1998-2005), deemed necessary to address chronically high unemployment and low average growth, contributed to strong growth and falling unemployment. These advances, as well as a government subsidized, reduced working hour scheme, help explain the relatively modest increase in unemployment during the 2008-09 recession - the deepest since World War II - and its decrease to 5.2% in 2014. The new German government introduced a minimum wage of about $11.60 (8.50 euros) per hour to take effect in 2015. Stimulus and stabilization efforts initiated in 2008 and 2009 and tax cuts introduced in Chancellor Angela MERKEL's second term increased Germany's total budget deficit - including federal, state, and municipal - to 4.1% in 2010, but slower spending and higher tax revenues reduced the deficit to 0.8% in 2011 and in 2012 Germany reached a budget surplus of 0.1%. The budget was essentially in balance in 2014. A constitutional amendment approved in 2009 limits the federal government to structural deficits of no more than 0.35% of GDP per annum as of 2016 though the target was already reached in 2012. The German economy suffers from low levels of investment, and a government plan to invest 15 billion euros 2016-18, largely in infrastructure, is intended to spur needed private investment. Following the March 2011 Fukushima nuclear disaster, Chancellor Angela MERKEL announced in May 2011 that eight of the country's 17 nuclear reactors would be shut down immediately and the remaining plants would close by 2022. Germany plans to replace nuclear power with renewable energy, which accounted for 27.8% of gross electricity consumption in 2014, up from 9% in 2000. Before the shutdown of the eight reactors, Germany relied on nuclear power for 23% of its electricity generating capacity and 46% of its base-load electricity production. Extremely low inflation, caused largely by low global energy prices and a weak euro, are expected to boost German GDP growth in 2015.

 

Source : CIA

 

Your inquiry: Carl Zeiss Meditech AG, Rudolf-Eber-Str. 11, D 73447 Oberkochen

 

 The subject of your inquiry is a branch. We are reporting on the headquarters.

 

 

 Company name and address

 

 CARL ZEISS MEDITEC AG

 

 Company Status:         active

                                    Göschwitzer Str. 51-52

                                    D 07745 Jena

                                    Telephone:03641/220-0

                                    Telefax:  03641/220-012

                                    Homepage: www.meditec-ag.zeiss.de

                                    E-mail:   info@meditec.zeiss.com

 

 VAT no.:                      DE811922737

 

 

 CONCLUSION

 

 Business relations are permissible.

 LEGAL FORM              Public limited company

 Date of foundation:      04.10.1995

 Registered on:             30.11.1995

 Commercial Register:   Local court 07745 Jena

 under:                          HRB 205623

 

 

 Share capital

 

 EUR                            81,309,610.00

 

 The company is listed on the stock market.

 

 Shareholder:

                      Carl Zeiss AG

                      Carl-Zeiss-Str. 22

                      D 73447 Oberkochen

                      Legal form:                     Public limited company

                      Share capital:                  EUR        120,000,000.00

                      Share:                                  65.000 %

                      Registered on:                22.03.2004

                      Reg. data:                       89073 Ulm, HRB 501555

 Shareholder:

                      ODDO et Cie.

                      12 Boulevard de la Madeleine

                      F 7500 Paris

                      Legal form:                     Other legal form

                      Share:                               3.040 %

 

 

President of the Board of Directors

 

                      Dr. Ludwig Monz

                      Pfarrer-Brantzen-Str. 48

                      D 55122 Mainz

                      born: 20.10.1963

 Member of the Board of Directors:

                      Thomas Simmerer

                      D 23628 Krummesse

                      born: 19.10.1962

 Member of the Board of Directors:

                      Dr. Christian Müller

                      Lise-Meitner-Weg 2

                      D 89129 Langenau

                      born: 03.08.1967

 President of the Supervisory Board:

                      Dr. Michael Kaschke

                      Wiesenweg 20

                      D 73447 Oberkochen

                      born: 18.06.1957

                      Profession: Physicist

 Vice-president of the Supervisory Board:

                      Dr. Markus Guthoff

                      D 47798 Krefeld

                      born: 12.05.1964

 Member of the Supervisory Board:

                      Thomas Spitzenpfeil

                      Schirnerstr. 24

                      D 41515 Grevenbroich

                      born: 22.12.1962

                      Profession: Businessman

                      Marital status: married

 Member of the Supervisory Board:

                      Dr. Carla Katharina Kriwet

                      D 20099 Hamburg

                      born: 01.03.1971

 Member of the Supervisory Board:

                      Cornelia Grandy

                      D 73447 Oberkochen

                      Marital status: unknown

 Member of the Supervisory Board:

                      Jörg Heinrich

                      D 07745 Jena

                      Marital status: unknown

 

 

Proxy

 

                      Jörg Roeper

                      Richard-Strauss-Weg 8

                      D 07743 Jena

                      authorized to jointly represent the company

                      born: 15.03.1962

 Proxy:

                      Falk Hartwig

                      Argelsrieder Str. 19a

                      D 81475 München

                      authorized to jointly represent the company

                      born: 25.05.1964

 Proxy:

                      Dr. Ralf Kuschnereit

                      828 Cascade DR

                      USA - Sunnyvale

                      authorized to jointly represent the company

                      born: 08.10.1968

 Proxy:

                      Jan Willem de Cler

                      NL  Rotterdam

                      authorized to jointly represent the company

                      born: 05.01.1965

                      Nationality: Dutch

 Proxy:

                      Dirk Brunner

                      USA  San Francisco, CA

                      authorized to jointly represent the company

                      born: 10.07.1970

                      Nationality: USA

 Proxy:

                      Dr. Till Sellschopp

                      D 99423 Weimar

                      authorized to jointly represent the company

                      born: 25.07.1976

 

 Further functions/participations of Dr. Christian Müller (Member

 of the Board of Directors)

 Manager:

                      Carl Zeiss Meditec Asset Management

                      Verwaltungsgesellschaft mbH

                      Göschwitzer Str. 51-52

                      D 07745 Jena

                      Legal form: Private limited company

                      Share capital:     EUR             25,000.00

                      Registered

                      on:         16.05.2000

                      Reg. data:  07745 Jena, HRB 208261

 

 

 COMPANY HISTORY

 

 04.10.1995 - 11.11.1999  AESCULAP - MEDITEC GMBH

                          Prüssingstr. 41

                          D 07745 Jena

                          Private limited company

 11.11.1999 - 22.02.2002  ASCLEPION-MEDITEC AG

                          Prüssingstr. 41

                          D 07745 Jena

                          Public limited company

 23.02.2002 - 04.07.2002  ASCLEPION-MEDITEC AG

                          Göschwitzer Str. 51-52

                          D 07745 Jena

                          Public limited company

 

 

 RESIGNED ACTING PERSONS AND SHAREHOLDERS

 

 11.03.2014 - 09.09.2014  Member of the Supervisory Board

                          Dr. Wolfgang Reim

                          D 19217 Campow

 

 

 BUSINESS ACTIVITIES

 

 Sectors

 32501   Manufacutre of technical instruments and supplies for   medical purposesn.e.c.

 46462   Wholesale of medical and orthopedic goods, dental and laboratory supplies

 96090   Other service activities n. e. c.

 

 BRANCHES AND FACTORIES

 

 Works:

                      Carl Zeiss Meditec AG

                      Carl-Zeiss-Promenade 10

                      D 07745 Jena

                      TEL.: 03641/643929

 Works:

                      Carl Zeiss Meditec AG

                      Kistlerhofstr. 75

                      D 81379 München

 Branch:

                      Carl Zeiss Meditec AG

                      Rudolf-Eber-Str. 11

                      D 73447 Oberkochen

                      TEL.: 07364/206000

 

 

 PARTICIPATIONS

 

 Shareholder:

                      Carl Zeiss Meditec Asset Management

                      Verwaltungsgesellschaft mbH

                      Göschwitzer Str. 51-52

                      D 07745 Jena

                      Legal form:         Private limited company

                      Company Status:            active

                      Share capital:      EUR             25,000.00

                      Share:                 EUR             25,000.00

                      Reg. data:           16.05.2000

                                                Local court 07745 Jena

                                                HRB 208261

 Shareholder:

                      S & V Technologies GmbH

                      Neuendorfstr. 20a

                      D 16761 Hennigsdorf

                      Legal form:         Private limited company

                      Company Status:            active

                      Share capital:     EUR            100,000.00

                      Share:                 EUR              2,000.00

                      Reg. data:           26.11.2013

                                                Local court 16816 Neuruppin

                                                HRB 10630 NP

 

 

 FINANCIAL INFORMATION

 

 Payment experience:  within agreed terms

 

 Negative information:We have no negative information at hand.

 

 Balance sheet year:  2013/2014

 

 

 REAL ESTATE

 

 Type of ownership:        proprietor

 Share:                          100.00 %

 Address                       Paintweg 10

                                    D 92685 Floß

 

 Type of ownership:       Tenant

 Address                       Göschwitzer Str. 51-52

                                    D 07745 Jena

 

 Land register documents were not available.

 

 

 BANKERS

 

 Principal bank

 DEUTSCHE BANK, 07703 JENA

 Sort. code: 82070000

 BIC: DEUTDE8EXXX

 

 Further banks

 COMMERZBANK VORMALS DRESDNER BANK, 07708 JENA

 Sort. code: 82080000

 BIC: DRESDEFF827

 UNICREDIT BANK - HYPOVEREINSBANK, 07704 JENA

 Sort. code: 83020087

 BIC: HYVEDEMM463

 

 

 FINANCIAL FIGURES

 

 Turnover:                     2012/2013          EUR        566,978,000.00

                                    2013/2014          EUR        587,488,000.00

 Profit:                          2012/2013          EUR         51,017,000.00

                                    2013/2014          EUR         57,135,000.00

 further business figures:

 Equipment:                                                      EUR          9,815,000.00

 Ac/ts receivable:                                              EUR        293,847,000.00

 Liabilities:                                            EUR         43,189,000.00

 Employees:                                                                 1,176

 - Trainees:                                                                    11

 

 

 BALANCE SHEETS

 

 Balance sheet ratios                 01.10.2013 - 30.09.2014

 Equity ratio [%]:                       87.24

 Liquidity ratio:                          7.61

 Return on total capital [%]:       6.59

 

 Balance sheet ratios                 01.10.2012 - 30.09.2013

 Equity ratio [%]:                       85.33

 Liquidity ratio:                          5.52

 Return on total capital [%]:       6.10

 

 Balance sheet ratios                 01.10.2011 - 30.09.2012

 Equity ratio [%]:                       83.12

 Liquidity ratio:                          10.00

 Return on total capital [%]:       5.71

 

 Balance sheet ratios                 01.10.2010 - 30.09.2011

 Equity ratio [%]:                       84.00

 Liquidity ratio:                          10.00

 Return on total capital [%]:       4.67

 

 Equity ratio

 The equity ratio indicates the portion of the equity as compared to the total capital. The higher the equity ratio, the better the economic stability (solvency) and thus the financial autonomy of a company.

 

 Liquidity ratio

 The liquidity ratio shows the proportion between adjusted receivables and net liabilities. The higher the ratio, the lower the company's financial dependancy from external creditors.

 

 Return on total capital

 The return on total capital shows the efficiency and return on the total capital employed in the company. The higher the return on total capital, the more economically does the company work with the invested capital.

 

 Balance sheet grade

 The balance sheet grade is based on the following ratios: equity ratio, liquidity ratio and return on total capital from the balance sheets published in the Federal Gazette. It is calculated in accordance with the methodology of Euler Hermes. It ranges from 1.0 (positive) to 5.0 (negative).

Financials

 

 Type of balance sheet:               Company balance sheet

 Origin of the present

 balance sheet:       electronic German Federal Gazette

 

 Financial year:      01.10.2013 - 30.09.2014

 

 ASSETS                                  EUR        949,040,000.00

  Fixed assets                           EUR        558,411,000.00

   Intangible assets                     EUR        167,458,000.00

    Concessions, licences, rights        EUR         86,783,000.00

    Goodwill                             EUR         80,675,000.00

   Tangible assets                       EUR         18,856,000.00

    Land / similar rights                EUR          2,847,000.00

    Plant / machinery                    EUR          4,621,000.00

    Other tangible assets / fixtures and

    fittings                             EUR          9,815,000.00

    Advance payments made / construction

    in progress                          EUR          1,573,000.00

   Financial assets                      EUR        372,097,000.00

    Shares in participations /

    subsidiaries and the like            EUR        251,895,000.00

     Shares in related companies         EUR        251,893,000.00

     Shares in investee companies        EUR              2,000.00

    Loans to participations /

    subsidiaries and the like            EUR        119,342,000.00

     Loans to related companies          EUR        119,342,000.00

    Other loans                          EUR            860,000.00

  Current assets                         EUR        381,982,000.00

   Stocks                                EUR         88,131,000.00

    Raw materials, consumables and

    supplies                             EUR         42,571,000.00

    Finished goods / work in progress    EUR         46,504,000.00

    Advance payments made                EUR            215,000.00

    Minus received advance payments for

    orders / installments for stocks     EUR         -1,159,000.00

   Accounts receivable                   EUR        293,847,000.00

    Trade debtors                        EUR         26,662,000.00

    Amounts due from related companies   EUR        261,022,000.00

    Amounts due from investee companies  EUR            186,000.00

    Other debtors and assets             EUR          5,977,000.00

   Liquid means                          EUR              4,000.00

  Remaining other assets                 EUR          8,647,000.00

   Accruals (assets)                     EUR            805,000.00

   Active difference from asset

   offsetting                            EUR          7,842,000.00

 

 LIABILITIES                             EUR        949,040,000.00

  Shareholders' equity                   EUR        833,592,000.00

   Capital                               EUR         81,310,000.00

    Subscribed capital (share capital)   EUR         81,310,000.00

   Reserves                              EUR        649,394,000.00

    Capital reserves                     EUR        646,454,000.00

    Retained earnings / revenue reserves EUR          2,940,000.00

   Balance sheet profit/loss (+/-)       EUR        102,888,000.00

    Balance sheet profit / loss          EUR        102,888,000.00

  Items between shareholders' equity and

  debt capital                           EUR            218,000.00

   Allowances / bonuses                  EUR            218,000.00

  Provisions                             EUR         54,826,000.00

   Provisions for taxes                  EUR          3,227,000.00

   Other / unspecified provisions        EUR         51,599,000.00

  Liabilities                            EUR         43,189,000.00

   Other liabilities                     EUR         43,189,000.00

    Trade creditors (for IAS incl. bills

    of exchange)                         EUR         19,739,000.00

    Liabililties due to related companiesEUR         20,883,000.00

    Liabilities due to investee companiesEUR            119,000.00

    Unspecified other liabilities        EUR          2,448,000.00

  Other liabilities                      EUR         17,215,000.00

   Deferrals (liabilities)               EUR          1,415,000.00

   Deferred taxes (not included under

   provisions/liabilities)               EUR         15,800,000.00

 

 PROFIT AND LOSS ACCOUNT (cost of sales method) according to Comm.

 Code (HGB)

  Sales                                  EUR        587,488,000.00

  Manufacturing costs                    EUR        314,348,000.00

  Gross result on sales                  EUR        273,140,000.00

  Distribution costs                     EUR         97,733,000.00

  General administration expenses        EUR         31,993,000.00

  Research and development costs         EUR         68,633,000.00

  Other operating income                 EUR         38,350,000.00

  Other operating expenses               EUR         25,354,000.00

  Operating result from continuing

  operations                             EUR         87,777,000.00

  Interest result (+/-)                  EUR         -3,412,000.00

   Interest and similar income           EUR          1,412,000.00

   Interest and similar expenses         EUR          4,824,000.00

  Other financial result                 EUR          1,483,000.00

   Income from securities and loans from

   financial assets                      EUR          1,483,000.00

  Financial result (+/-)                 EUR         -1,929,000.00

  Result from ordinary operations (+/-)  EUR         85,848,000.00

  Extraordinary result (+/-)             EUR           -748,000.00

  Income tax / refund of income tax (+/-)EUR        -27,965,000.00

  Tax (+/-)                              EUR        -27,965,000.00

  Annual surplus / annual deficit        EUR         57,135,000.00

 

 Type of balance

 sheet:               Company balance sheet

 Origin of the present

 balance sheet:       electronic German Federal Gazette

 

 Financial year:      01.10.2012 - 30.09.2013

 

 ASSETS                                  EUR        943,884,000.00

  Fixed assets                           EUR        572,160,000.00

   Intangible assets                     EUR        180,036,000.00

    Concessions, licences, rights        EUR         92,026,000.00

    Goodwill                             EUR         88,010,000.00

   Tangible assets                       EUR         19,983,000.00

    Land / similar rights                EUR          3,227,000.00

    Plant / machinery                    EUR          4,618,000.00

    Other tangible assets / fixtures and

    fittings                             EUR         10,879,000.00

    Advance payments made / construction

    in progress                          EUR          1,259,000.00

   Financial assets                      EUR        372,141,000.00

    Shares in participations /

    subsidiaries and the like            EUR        239,372,000.00

     Shares in related companies         EUR        239,370,000.00

     Shares in investee companies        EUR              2,000.00

    Loans to participations /

    subsidiaries and the like            EUR        131,930,000.00

     Loans to related companies          EUR        131,930,000.00

    Other loans                          EUR            839,000.00

  Current assets                         EUR        363,240,000.00

   Stocks                                EUR         85,394,000.00

    Raw materials, consumables and

    supplies                             EUR         42,071,000.00

    Finished goods / work in progress    EUR         44,288,000.00

    Advance payments made                EUR            216,000.00

    Minus received advance payments for

    orders / installments for stocks     EUR         -1,181,000.00

   Accounts receivable                   EUR        277,843,000.00

    Trade debtors                        EUR         20,993,000.00

    Amounts due from related companies   EUR        255,907,000.00

    Amounts due from investee companies  EUR             14,000.00

    Other debtors and assets             EUR            929,000.00

   Liquid means                          EUR              3,000.00

  Remaining other assets                 EUR          8,484,000.00

   Accruals (assets)                     EUR            990,000.00

   Active difference from asset

   offsetting                            EUR          7,494,000.00

 

 LIABILITIES                             EUR        943,884,000.00

  Shareholders' equity                   EUR        813,046,000.00

   Capital                               EUR         81,310,000.00

    Subscribed capital (share capital)   EUR         81,310,000.00

   Reserves                              EUR        649,394,000.00

    Capital reserves                     EUR        646,454,000.00

    Retained earnings / revenue reserves EUR          2,940,000.00

   Balance sheet profit/loss (+/-)       EUR         82,342,000.00

    Balance sheet profit / loss          EUR         82,342,000.00

  Items between shareholders' equity and

  debt capital                           EUR            333,000.00

   Allowances / bonuses                  EUR            333,000.00

  Provisions                             EUR         55,223,000.00

   Provisions for taxes                  EUR          6,736,000.00

   Other / unspecified provisions        EUR         48,487,000.00

  Liabilities                            EUR         55,171,000.00

   Other liabilities                     EUR         55,171,000.00

    Trade creditors (for IAS incl. bills

    of exchange)                         EUR         25,829,000.00

    Liabililties due to related companiesEUR         25,803,000.00

    Liabilities due to investee companiesEUR            189,000.00

    Unspecified other liabilities        EUR          3,350,000.00

  Other liabilities                      EUR         20,111,000.00

   Deferrals (liabilities)               EUR          1,146,000.00

   Deferred taxes (not included under

   provisions/liabilities)               EUR         18,965,000.00

  Guarantees and other commitments       EUR          6,924,000.00

   Guarantees / warranties               EUR          6,924,000.00

    Guarantees                           EUR          6,924,000.00

 

 PROFIT AND LOSS ACCOUNT (cost of sales method) according to Comm.

 Code (HGB)

  Sales                                  EUR        566,978,000.00

  Manufacturing costs                    EUR        321,750,000.00

  Gross result on sales                  EUR        245,228,000.00

  Distribution costs                     EUR         91,105,000.00

  General administration expenses        EUR         34,701,000.00

  Research and development costs         EUR         67,804,000.00

  Other operating income                 EUR         46,181,000.00

  Other operating expenses               EUR         12,969,000.00

  Operating result from continuing

  operations                             EUR         84,830,000.00

  Interest result (+/-)                  EUR         -4,550,000.00

   Interest and similar income           EUR          1,334,000.00

   Interest and similar expenses         EUR          5,884,000.00

  Other financial result                 EUR          2,808,000.00

   Income from securities and loans from

   financial assets                      EUR          2,808,000.00

  Financial result (+/-)                 EUR         -1,742,000.00

  Result from ordinary operations (+/-)  EUR         83,088,000.00

  Extraordinary expenses                 EUR            748,000.00

  Extraordinary result (+/-)             EUR           -748,000.00

  Income tax / refund of income tax (+/-)EUR        -31,323,000.00

  Tax (+/-)                              EUR        -31,323,000.00

  Annual surplus / annual deficit        EUR         51,017,000.00

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.66.14

UK Pound

1

Rs.100.55

Euro

1

Rs.71.27

 

INFORMATION DETAILS

 

Analysis Done by :

DIV

 

 

Report Prepared by :

ASH

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.